embecta to Report Fiscal First Quarter Financial Results
Rhea-AI Summary
embecta (Nasdaq: EMBC) will report fiscal first quarter 2026 results and host a conference call on Thursday, February 5, 2026 at 8:00 a.m. ET. The call will include an operational update and a Q&A session. Investors can access a live webcast or teleconference, and a webcast replay will be available beginning at 11:00 a.m. ET on February 5, 2026 and archived on the embecta investor relations website for one year.
Positive
- None.
Negative
- None.
News Market Reaction – EMBC
In the Jan 23 session, EMBC declined 9.44%, reflecting a notable negative market reaction. Argus tracked a trough of -3.0% from its starting point during tracking. Our momentum scanner triggered 23 alerts that day, indicating elevated trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 11 | Earnings date notice | Neutral | +2.0% | Set Q4 and full-year 2025 results date and access details for call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Limited history for earnings-date notices; the prior event saw a modest positive move of about 1.97% on the day.
Recent disclosures show EMBC steadily communicating around key events. An earlier Nov 11, 2025 earnings-date notice preceded Q4/FY2025 results and guidance. Subsequent filings detailed full-year financials, governance changes, and strategic focus on diabetes-care devices. Today’s announcement continues this pattern of scheduling earnings calls with webcast access and replay details for investors.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PARSIPPANY, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal first quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Thursday, February 5, 2026.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on February 5, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
| Contacts: | |
| Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations | Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |
